SlideShare una empresa de Scribd logo
1 de 30
Koonal Shah, Office of Health Economics
Oliver Rivero-Arias, National Perinatal Epidemiology Unit,
Nuffield Department of Population Health, University of Oxford
NICE Technical Forum  29 January 2019
Generating preference-based
values for the EQ-5D-Y to support
its use in HTA
NICE Technical Forum, 29 January 2019
2
Acknowledgements
• This presentation reports selected methods and findings from
research supported by grants from the EuroQol Research
Foundation and the Spanish Department of Health
• The views expressed do not necessarily reflect the views of
the funders
NICE Technical Forum, 29 January 2019
3
Outline
• Introduction to measuring and valuing child health
• EQ-5D-Y
• Brief primer on QALYs, measurement and valuation
• Valuation challenges
• Findings from recent EQ-5D-Y valuation research
• Suggested points for discussion
NICE Technical Forum, 29 January 2019
4
Measuring and valuing child health
• Increasing research and HTA interest in measuring and valuing the
health of children and adolescents
• Measures available for measuring child health, e.g. PedQL, KIDSCREEN
• These measures provide summary scores across dimensions, but are
not preference-based
• Not suitable for use in the estimation of QALYs
• Generic preference-based measures developed specifically for use in
younger populations are also now available – HUI2, CHU9D
• EQ-5D-Y – ‘youth’ version of the EQ-5D
NICE Technical Forum, 29 January 2019
5
EQ-5D-Y instrument
Developed in 2010 for use in children
and adolescents aged 8 to 15 years
NICE Technical Forum, 29 January 2019
6
Brief primer on QALYs, description
and valuation
• Quality-adjusted life years: a
measure of health captures both
quality of life and length of life
• Quality of life is used to ‘weight’
patients’ life years
• Quality of life scale is anchored at
1 = full health, 0 = dead
• 1 QALY = a year of perfect health
Time (Years)
Quality
of life
scale
(0-1)
0
1 Health profile of
a CF adolescent
with current
treatment
Mild State
Moderate State
Severe State
Transplant State
40
NICE Technical Forum, 29 January 2019
7
Brief primer on QALYs, description
and valuation
• The ‘quality adjustment’ in QALYs requires two pieces of
information:
1. A description of patients’ health (e.g. using self/proxy-reported EQ-
5D-Y health states)…
2. …and the valuation (on a scale anchored at 0 and 1) of those health
states
NICE Technical Forum, 29 January 2019
8
For every health
state, there is a
‘value’ on a 0-1
anchored scale
Obtaining ‘values’ for health states
NICE Technical Forum, 29 January 2019
9
Example of an EQ-5D ‘value set’
NICE Technical Forum, 29 January 2019
10
How do we get the values?
• We typically ask members of the general public to
complete stated preference ‘choice-based’ exercises
• These involve considering a range of different health
states, imagining what it would be like to experience
them, and indicating how good or bad they are
• For decision making, we need a set of ‘values’ that
represents the overall view of the relevant population
• Preference elicitation techniques:
• Rating scale (RS)
• Standard gamble (SG)
• Time trade-off (TTO)
• Discrete choice experiment (DCE)
NICE Technical Forum, 29 January 2019
11
EQ-5D-Y: state of play
• >40 language versions available
• Use is modest but growing
• Demand for use in HTA, but no value sets to support that
• Recent research has indicated that regular EQ-5D-3L value sets
cannot be used for children and adolescents
NICE Technical Forum, 29 January 2019
12
Valuation challenges
• Normative issues (whose preferences should we elicit?)
• Perspective issues (whose health should we elicit the
preferences for?)
• Methods issues (how do we elicit the preferences, and on what
basis do we make this choice?)
• VAS values lower for EQ-5D-Y than for EQ-5D-3L (Kind et al., 2015)
• TTO values higher for EQ-5D-Y (Kreimeier et al., 2015) – possibly
due to reluctance to sacrifice life years for children
NICE Technical Forum, 29 January 2019
13
Whose preferences?
• Position adopted by decision makers in the UK, US, Netherlands
(amongst others): relevant preferences are those of the
general public
• EuroQol protocol: EQ-5D value sets should be based on the
preferences of the general public, not of the subgroup whose
health is being evaluated
• Reflects fact that HTA is intended to inform the broad allocation of
resources across an entire population / health system
• Public = taxpayers and potential users of health care
• Societal perspective, insurance principle, adaptation arguments
NICE Technical Forum, 29 January 2019
14
Who counts as the public?
• The UK is not prescriptive about who constitutes a member of
the public, but there seems to be an implicit consensus:
• Those who bear the cost of providing health care
• Those eligible to vote
• These criteria exclude children and adolescents
NICE Technical Forum, 29 January 2019
15
Alternative view
• Preferences of children and adolescents are relevant because
they are potential patients / users of the health care being
evaluated
• May be relevant to understand the preferences of children (as
patients) – could be relevant in other, non-HTA uses of the
instrument (Versteegh and Brouwer, 2016)
• Alternatives to conventional techniques now available that may
be suitable for eliciting the preferences of younger people
NICE Technical Forum, 29 January 2019
16
15. To put the above principles into practice on matters that affect children
and young people’s health and wellbeing, NICE has adopted the
following overarching aim:
• To involve children and young people, (and the organisations that
represent their interests), on matters pertinent to NICE’s work and
that affect children and young people’s health and wellbeing.
16. In pursuit of this aim, NICE is committed to:
• ensuring that the perspectives of children and young people –
including those who share the protected characteristics of the
Equality Act 20102 or live in disadvantaged circumstances – are
taken into account in relevant areas of NICE’s work
• producing guidance and standards on topics covering children and
young people’s health and wellbeing, which have been informed and
influenced by their views and experiences
Extract from NICE Patient and Public
Involvement Policy (pp.6-7)
NICE Technical Forum, 29 January 2019
17
Whose health?
• If we are to use adult preferences to value child health
instruments, whose health should they be valuing?
• Their own health?
• Their own health, imagining they are a child?
• The health of their own child?
• The health of an unidentified child?
– How old should the child be, given the range of ages covered by
different instruments?
NICE Technical Forum, 29 January 2019
18
What approaches have been used to develop value
sets of instruments for paediatric populations?
Instrument Country Sample Perspective Elicitation
method
QWB USA Adults Self RS
HUI Mark 2 Canada Adults Child perspective SG/RS
HUI Mark 3 Canada Adults Self SG/RS
16D Finland Adolescents Self RS
17D Finland Adults Child perspective RS
AQoL-6D Australia Adolescents Self TTO
AHUM UK Adults Self TTO
CHU-9D UK Adults Self SG
CHU-9D Australia Adolescents Self DCE
EQ-5D-Y USA Adults Child perspective DCE
QWB: Quality of Well-Being Scale; HUI: Health Utility Index; 16D: sixteen-
dimensional measure of health-related quality of life; 17D: seventeen-
dimensional measure of health-related quality of life; AQoL-6D: Assessment of
Quality of Life 6-Dimension; CHU-9D: Child Health Utility 9D; AHUM: Adolescent
Health Utility Measure; RS: rating scale, SG: standard gamble, TTO: time trade-
off; DCE: discrete choice experiment
NICE Technical Forum, 29 January 2019
19
Recent EQ-5D-Y valuation research
• Conduct a discrete choice experiment to obtain preferences for EQ-5D-Y
health states using a sample of adults. Values obtained on a latent scale
(not a QALY scale)
Study 1: Latent scale DCE study – adult version
Study 3: Anchoring study
• In parallel, test a range of methods for anchoring latent scale values at
0 = dead to convert latent scale of DCE values into QALY scale
• Not covered in this presentation
Study 2: Latent scale DCE study – adolescent version
• Replicate study 1 using a sample of adolescents
NICE Technical Forum, 29 January 2019
20
Study 1: Latent Scale DCE Adults
• Online discrete choice experiment (DCE) survey
• Participants belonging to an online panel: quotas used for
gender, age and social grade
NICE Technical Forum, 29 January 2019
21
Study 1: Latent Scale DCE Adults
• 1,000 adults (+18) completing the survey from
the perspective of a “10-year old child”
• We used a Blocked Bayesian efficient design to
identify 150 pairs to present to participants
• + fixed pair (one health state clearly dominant)
• Survey instrument included: consent/screening,
self-reported EQ-5D-Y, DCE exercise, debriefing,
background questions
• Data collection during February-March 2017
NICE Technical Forum, 29 January 2019
22
Study 1: Latent Scale DCE Adults
• Discrete choice modelling used to analysis
DCE data
• multinomial logit, scaled multinomial logit;
mixed logit; generalised multinomial logit and
latent class
• Relative attribute importance of model
parameters of EQ-5D-Y levels
• Participant engagement with the
elicitation task
NICE Technical Forum, 29 January 2019
23
Study 2: Latent Scale DCE Adolescents
• Same design of Study 1
• 1,005 adolescents (11-17 years old)
completing the survey from their own
perspective
• Data collection during February-March
2018
NICE Technical Forum, 29 January 2019
24
Selected background characteristics
Adolescents
(own health)
(n=1,005)
Adults
(child perspective)
(n=1,000)
Family affluence scale (FAS)
Low FAS score 29 (2.9%) -
Medium FAS score 456 (45.4%) -
High FAS score 519 (51.6%) -
Missing values 1 (0.1%)
Education
Did not continue education - 230 (23.0%)
Continued education (no degree) - 315 (31.5%)
Continued education (degree) - 455 (45.5%)
Experience of serious illness
In self - 312 (31.2%)
In friends or family - 629 (62.9%)
In caring for others - 279 (27.9%)
Self-reported health
EQ-5D-Y health state 11111 587 (58.4%) 148 (14.8%)
Other EQ-5D-Y health states 418 (41.6%) 852 (85.2%)
Samples were
representative
of the UK
general
population in
terms of age,
gender, grade
and nation
NICE Technical Forum, 29 January 2019
25
Relative attribute importance model
parameters of EQ-5D-Y levels
Levels
Adolescents
(own health)
Mean (95% CI)
Adults
(child perspective)
Mean (95% CI)
Statistically significant
differences in
preferences?
MO2 Some problems 3.7 (2.8 to 4.7) 3.2 (2.3 to 4.1)
MO3 Lot of problems 12.9 (11.9 to 13.9) 9.4 (8.3 to 10.5) *
SC2 Some problems 3 (2.2 to 3.8) 2.9 (2.1 to 3.6)
SC3 Lot of problems 10.2 (9.2 to 11.2) 7.7 (6.7 to 8.6)
UA2 Some problems 4.5 (3.8 to 5.3) 4.8 (4 to 5.5)
UA3 Lot of problems 12.1 (11.2 to 13.1) 11.6 (10.7 to 12.5)
PD2 Some pain 7.5 (6.5 to 8.4) 8.8 (7.9 to 9.7)
PD3 Lot of pain 21.1 (19.6 to 22.7) 24 (22.2 to 25.7) *
AD2 Bit worried 5.2 (4.3 to 6) 7.4 (6.5 to 8.4) *
AD3 Very worried 19.7 (18.1 to 21.3) 20.3 (18.7 to 21.9) *
MO: Mobility; SC: Self-care; UA: Usual activities; PD: Pain/Discomfort;
AD: Worried, sad or unhappy
Red figures indicate three parameters with largest contributions
NICE Technical Forum, 29 January 2019
26
Participant engagement with DCE
State 11122 vs 22233 Adolescents Adults
Proportion selecting state
11122
88.46% 89.5%
Adults (child perspective)Adolescents
NICE Technical Forum, 29 January 2019
27
Debriefing questions (freq.,%)
Adolescents Adults
Found the tasks difficult:
Strongly disagree 208 (20.70%) 217 (21.70%)
Disagree 307 (30.55%) 290 (29.00%)
Neither agree nor disagree 224 (22.29%) 226 (22.60%)
Agree 226 (22.49%) 224 (22.40%)
Strongly agree 40 (3.98%) 43 (4.30%)
Found difficult to imagine the
health problems described
Strongly disagree 105 (10.45%) 185 (18.50%)
Disagree 248 (24.68%) 329 (32.90%)
Neither agree nor disagree 213 (21.19%) 209 (20.90%)
Agree 369 (36.72%) 206 (20.60%)
Strongly agree 70 (6.97%) 71 (7.10%)
NICE Technical Forum, 29 January 2019
28
• DCE did not include dead or a duration attribute, so values are
on a ‘latent’ (or undefined) scale
• Further info needed to rescale latent scale values so that they
are anchored at 0 and 1, as required for QALY calculations
• Which anchoring method should be used? Possible criteria:
• Feasibility
• Acceptability to decision makers
• Potential for administration online
• Theoretical and empirical coherence with the preference data to be
anchored
• Theoretical and empirical consistency with adult valuations in
use in HTA
Need for anchoring
NICE Technical Forum, 29 January 2019
29
Some discussion points
• Which perspective should be employed?
• Is the relevant and realistic to use adolescent preferences?
• How important is it that the methods used for child health health
valuation are commensurate with those used for adult health
valuation?
• Which stakeholders should feed into these decisions?
NICE Technical Forum, 29 January 2019
30
To enquire about additional information and analyses, please contact
Koonal Shah at kshah@ohe.org
To keep up with the latest news and research, subscribe to our blog, OHE News
Follow us on Twitter @OHENews, LinkedIn and SlideShare
Office of Health Economics (OHE)
Southside, 7th Floor
105 Victoria Street
London SW1E 6QT
United Kingdom
+44 20 7747 8850
www.ohe.org
OHE’s publications may be downloaded free of charge from our website.
Thank you for listening

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

Valuing the health and wellbeing aspects of Community Empowerment (CE) in an ...
Valuing the health and wellbeing aspects of Community Empowerment (CE) in an ...Valuing the health and wellbeing aspects of Community Empowerment (CE) in an ...
Valuing the health and wellbeing aspects of Community Empowerment (CE) in an ...
 
Panel 2 Patricia Clarke
Panel 2 Patricia ClarkePanel 2 Patricia Clarke
Panel 2 Patricia Clarke
 
Local Transformation Plans Review
Local Transformation Plans ReviewLocal Transformation Plans Review
Local Transformation Plans Review
 
Running Horse Group - Event Outcomes (25th May 2018)
Running Horse Group - Event Outcomes (25th May 2018) Running Horse Group - Event Outcomes (25th May 2018)
Running Horse Group - Event Outcomes (25th May 2018)
 
Rca webinar jan 2016
Rca webinar jan 2016Rca webinar jan 2016
Rca webinar jan 2016
 
The “German HPU Network” and the Role of Networks
The “German HPU Network” and the Role of NetworksThe “German HPU Network” and the Role of Networks
The “German HPU Network” and the Role of Networks
 
Suwatha piyasa ministry of health department
Suwatha piyasa ministry of health departmentSuwatha piyasa ministry of health department
Suwatha piyasa ministry of health department
 
Cochrane reviews and guideline development: Is there anything new under the sun?
Cochrane reviews and guideline development: Is there anything new under the sun?Cochrane reviews and guideline development: Is there anything new under the sun?
Cochrane reviews and guideline development: Is there anything new under the sun?
 
Medical education research presentation basic
Medical education research presentation  basicMedical education research presentation  basic
Medical education research presentation basic
 
2015 CV
2015 CV2015 CV
2015 CV
 
Reshaping Care for Frail Older People in Scotland (WS34)
Reshaping Care for Frail Older People in Scotland (WS34)Reshaping Care for Frail Older People in Scotland (WS34)
Reshaping Care for Frail Older People in Scotland (WS34)
 
Volberding GHS Research 10 11 12
Volberding GHS Research 10 11 12Volberding GHS Research 10 11 12
Volberding GHS Research 10 11 12
 
APHA2011 Academic Health Department Learning Community Meeting
APHA2011 Academic Health Department Learning Community MeetingAPHA2011 Academic Health Department Learning Community Meeting
APHA2011 Academic Health Department Learning Community Meeting
 
UUK AHSN discussion - higher education and health research
UUK AHSN discussion - higher education and health researchUUK AHSN discussion - higher education and health research
UUK AHSN discussion - higher education and health research
 
Prioritisation in Public Health: Overview of Health Economics Approaches
Prioritisation in Public Health: Overview of Health Economics ApproachesPrioritisation in Public Health: Overview of Health Economics Approaches
Prioritisation in Public Health: Overview of Health Economics Approaches
 
Day 2: Innovation to optimise therapeutic options for prevention and treatmen...
Day 2: Innovation to optimise therapeutic options for prevention and treatmen...Day 2: Innovation to optimise therapeutic options for prevention and treatmen...
Day 2: Innovation to optimise therapeutic options for prevention and treatmen...
 
APA 2015_LM Brady involving cyp in research_03.15
APA 2015_LM Brady involving cyp in research_03.15APA 2015_LM Brady involving cyp in research_03.15
APA 2015_LM Brady involving cyp in research_03.15
 
Developing an ICF-based mobile application (mICF) to improve continuity of ca...
Developing an ICF-based mobile application (mICF) to improve continuity of ca...Developing an ICF-based mobile application (mICF) to improve continuity of ca...
Developing an ICF-based mobile application (mICF) to improve continuity of ca...
 
Autism crc briefing autism summit
Autism crc briefing autism summitAutism crc briefing autism summit
Autism crc briefing autism summit
 
Tackling societal challenges through digital transformation
Tackling societal challenges through digital transformationTackling societal challenges through digital transformation
Tackling societal challenges through digital transformation
 

Similar a Generating preference-based values for the EQ-5D-Y to support its use in HTA

Tele Health The Improvement Process of Healthcare among Elderly during the CO...
Tele Health The Improvement Process of Healthcare among Elderly during the CO...Tele Health The Improvement Process of Healthcare among Elderly during the CO...
Tele Health The Improvement Process of Healthcare among Elderly during the CO...
YogeshIJTSRD
 
Indicators and dilemma of breast feeding assessment last
Indicators and dilemma of breast feeding assessment last Indicators and dilemma of breast feeding assessment last
Indicators and dilemma of breast feeding assessment last
Tarek Al 3reeny
 
Engaging extension in health reform 4 16 2013
Engaging extension in health reform 4 16 2013Engaging extension in health reform 4 16 2013
Engaging extension in health reform 4 16 2013
Cynthia Reeves
 
NCCMT Spotlight Webinar: Action Framework for Equity-Integrated Population He...
NCCMT Spotlight Webinar: Action Framework for Equity-Integrated Population He...NCCMT Spotlight Webinar: Action Framework for Equity-Integrated Population He...
NCCMT Spotlight Webinar: Action Framework for Equity-Integrated Population He...
The National Collaborating Centre for Methods and Tools
 
GrandRound-Cancer.pptx
GrandRound-Cancer.pptxGrandRound-Cancer.pptx
GrandRound-Cancer.pptx
suyash255452
 

Similar a Generating preference-based values for the EQ-5D-Y to support its use in HTA (20)

The EQ-5D and Its Use Internationally
The EQ-5D and Its Use InternationallyThe EQ-5D and Its Use Internationally
The EQ-5D and Its Use Internationally
 
What's new in the uk nsc
What's new in the uk nscWhat's new in the uk nsc
What's new in the uk nsc
 
23 setembre 2014 fundacio idiap jordi gol health consensus reduced
23 setembre 2014 fundacio idiap jordi gol health consensus reduced23 setembre 2014 fundacio idiap jordi gol health consensus reduced
23 setembre 2014 fundacio idiap jordi gol health consensus reduced
 
Tele Health The Improvement Process of Healthcare among Elderly during the CO...
Tele Health The Improvement Process of Healthcare among Elderly during the CO...Tele Health The Improvement Process of Healthcare among Elderly during the CO...
Tele Health The Improvement Process of Healthcare among Elderly during the CO...
 
Indicators and dilemma of breast feeding assessment last
Indicators and dilemma of breast feeding assessment last Indicators and dilemma of breast feeding assessment last
Indicators and dilemma of breast feeding assessment last
 
Responding to Non COVID-19: Identification of deterioration in children
Responding to Non COVID-19: Identification of deterioration in childrenResponding to Non COVID-19: Identification of deterioration in children
Responding to Non COVID-19: Identification of deterioration in children
 
Economic evaluation: overview
Economic evaluation: overviewEconomic evaluation: overview
Economic evaluation: overview
 
Utilización de la evidencia cualitativa para mejorar la inclusión de las pref...
Utilización de la evidencia cualitativa para mejorar la inclusión de las pref...Utilización de la evidencia cualitativa para mejorar la inclusión de las pref...
Utilización de la evidencia cualitativa para mejorar la inclusión de las pref...
 
M-E for OVC programs presentation.pptx
M-E for OVC programs presentation.pptxM-E for OVC programs presentation.pptx
M-E for OVC programs presentation.pptx
 
Indicators for assessing infant and young child feeding practices Part 1 Defi...
Indicators for assessing infant and young child feeding practices Part 1 Defi...Indicators for assessing infant and young child feeding practices Part 1 Defi...
Indicators for assessing infant and young child feeding practices Part 1 Defi...
 
Towards a Grand Convergence for Child Survival and Health
Towards a Grand Convergence for Child Survival and HealthTowards a Grand Convergence for Child Survival and Health
Towards a Grand Convergence for Child Survival and Health
 
Engaging extension in health reform 4 16 2013
Engaging extension in health reform 4 16 2013Engaging extension in health reform 4 16 2013
Engaging extension in health reform 4 16 2013
 
RIWC_PARA_A186 who, global disability action plan....
RIWC_PARA_A186 who, global disability action plan....RIWC_PARA_A186 who, global disability action plan....
RIWC_PARA_A186 who, global disability action plan....
 
NCCMT Spotlight Webinar: Action Framework for Equity-Integrated Population He...
NCCMT Spotlight Webinar: Action Framework for Equity-Integrated Population He...NCCMT Spotlight Webinar: Action Framework for Equity-Integrated Population He...
NCCMT Spotlight Webinar: Action Framework for Equity-Integrated Population He...
 
Seeking value: Experience from the UK's National Institute for Health and Car...
Seeking value: Experience from the UK's National Institute for Health and Car...Seeking value: Experience from the UK's National Institute for Health and Car...
Seeking value: Experience from the UK's National Institute for Health and Car...
 
“Quality assessment guidebook A guide to assessing health services for adole...
 “Quality assessment guidebook A guide to assessing health services for adole... “Quality assessment guidebook A guide to assessing health services for adole...
“Quality assessment guidebook A guide to assessing health services for adole...
 
Challenges in measurement in longitudinal studies
Challenges in measurement in longitudinal studiesChallenges in measurement in longitudinal studies
Challenges in measurement in longitudinal studies
 
GrandRound-Cancer.pptx
GrandRound-Cancer.pptxGrandRound-Cancer.pptx
GrandRound-Cancer.pptx
 
Neonatal screening for inborn errors of metabolism
Neonatal screening  for inborn errors of metabolismNeonatal screening  for inborn errors of metabolism
Neonatal screening for inborn errors of metabolism
 
Vabpro and fundamentals to value based procurement
Vabpro and fundamentals to value based procurementVabpro and fundamentals to value based procurement
Vabpro and fundamentals to value based procurement
 

Más de Office of Health Economics

Más de Office of Health Economics (20)

Annual lecture
Annual lecture Annual lecture
Annual lecture
 
Devlin ispor 2020 issues panel 20.05.20
Devlin ispor 2020 issues panel 20.05.20 Devlin ispor 2020 issues panel 20.05.20
Devlin ispor 2020 issues panel 20.05.20
 
Towse 2020 antimicrobials melbourne final
Towse 2020 antimicrobials melbourne finalTowse 2020 antimicrobials melbourne final
Towse 2020 antimicrobials melbourne final
 
Towse cgd price transparency seminar
Towse cgd price transparency seminarTowse cgd price transparency seminar
Towse cgd price transparency seminar
 
OHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
OHE presents at G20 AMR-R&D meeting in Paris - Adrian TowseOHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
OHE presents at G20 AMR-R&D meeting in Paris - Adrian Towse
 
Pricing in emerging markets: options to get value for money - Adrian Towse
Pricing in emerging markets: options to get value for money - Adrian TowsePricing in emerging markets: options to get value for money - Adrian Towse
Pricing in emerging markets: options to get value for money - Adrian Towse
 
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...
% GDP spending in UK, G5 countries and OECD upper middle income countries.  W...% GDP spending in UK, G5 countries and OECD upper middle income countries.  W...
% GDP spending in UK, G5 countries and OECD upper middle income countries. W...
 
The role of real world data and evidence in building a sustainable & efficien...
The role of real world data and evidence in building a sustainable & efficien...The role of real world data and evidence in building a sustainable & efficien...
The role of real world data and evidence in building a sustainable & efficien...
 
ISPOR Education Symposium- Go where the money is
ISPOR Education Symposium- Go where the money isISPOR Education Symposium- Go where the money is
ISPOR Education Symposium- Go where the money is
 
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
Role Substitution, Skill Mix, and Provider Efficiency and Effectiveness : Les...
 
IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
 IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY? IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
IS INDICATION BASED PRICING FEASIBLE AND/OR BENEFICIAL FOR SOCIETY?
 
Ispor 2019 poster - Patricia Cubi-Molla
Ispor 2019 poster - Patricia Cubi-MollaIspor 2019 poster - Patricia Cubi-Molla
Ispor 2019 poster - Patricia Cubi-Molla
 
Understanding what aspects of health and quality of life are important to people
Understanding what aspects of health and quality of life are important to peopleUnderstanding what aspects of health and quality of life are important to people
Understanding what aspects of health and quality of life are important to people
 
Novel approaches for valuing health at the end of life
Novel approaches for valuing health at the end of lifeNovel approaches for valuing health at the end of life
Novel approaches for valuing health at the end of life
 
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
Assessing the Life-Cycle Value Added of Second Generation Antipsychotics in S...
 
HTA and payment mechanisms for new drugs to tackle AMR
HTA and payment mechanisms for new drugs to tackle AMRHTA and payment mechanisms for new drugs to tackle AMR
HTA and payment mechanisms for new drugs to tackle AMR
 
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
Assessing the Life-cycle Value Added of Second-Generation Antipsychotics in S...
 
Pay for Performance for Specialised Care in England
Pay for Performance for Specialised Care in EnglandPay for Performance for Specialised Care in England
Pay for Performance for Specialised Care in England
 
Real option value drugs: is it really an option?
Real option value drugs: is it really an option?Real option value drugs: is it really an option?
Real option value drugs: is it really an option?
 
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
MCDA OR WEIGHTED CEA BASED ON THE QALY? WHICH IS THE FUTURE FOR HTA DECISION ...
 

Último

Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetNanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Thoothukudi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Thoothukudi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetThoothukudi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Thoothukudi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Bhagalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Bhagalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetBhagalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Bhagalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Muzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Muzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetMuzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Muzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
bhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
bhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetbhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
bhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Call Girls in Udaipur Girija Udaipur Call Girl ✔ VQRWTO ❤️ 100% offer with...
Call Girls in Udaipur  Girija  Udaipur Call Girl  ✔ VQRWTO ❤️ 100% offer with...Call Girls in Udaipur  Girija  Udaipur Call Girl  ✔ VQRWTO ❤️ 100% offer with...
Call Girls in Udaipur Girija Udaipur Call Girl ✔ VQRWTO ❤️ 100% offer with...
mahaiklolahd
 
Sambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Sambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetSambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Sambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetMangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Rajkot Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Rajkot Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetRajkot Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Rajkot Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
jabalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
jabalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetjabalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
jabalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Top 20 Famous Indian Female Pornstars Name List 2024
Top 20 Famous Indian Female Pornstars Name List 2024Top 20 Famous Indian Female Pornstars Name List 2024
Top 20 Famous Indian Female Pornstars Name List 2024
Sheetaleventcompany
 
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in LahoreBest Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
Deny Daniel
 
ooty Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
ooty Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetooty Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
ooty Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
dehradun Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
dehradun Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetdehradun Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
dehradun Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
Jalna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Jalna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetJalna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Jalna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 
kochi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
kochi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetkochi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
kochi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Call Girls Service
 

Último (20)

Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetNanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Nanded Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Thoothukudi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Thoothukudi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetThoothukudi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Thoothukudi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Bhagalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Bhagalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetBhagalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Bhagalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Muzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Muzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetMuzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Muzaffarpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
bhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
bhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetbhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
bhubaneswar Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Call Girls in Udaipur Girija Udaipur Call Girl ✔ VQRWTO ❤️ 100% offer with...
Call Girls in Udaipur  Girija  Udaipur Call Girl  ✔ VQRWTO ❤️ 100% offer with...Call Girls in Udaipur  Girija  Udaipur Call Girl  ✔ VQRWTO ❤️ 100% offer with...
Call Girls in Udaipur Girija Udaipur Call Girl ✔ VQRWTO ❤️ 100% offer with...
 
Sambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Sambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetSambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Sambalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetMangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Mangalore Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Rajkot Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Rajkot Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetRajkot Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Rajkot Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Dehradun Call Girls 8854095900 Call Girl in Dehradun Uttrakhand
Dehradun Call Girls 8854095900 Call Girl in Dehradun  UttrakhandDehradun Call Girls 8854095900 Call Girl in Dehradun  Uttrakhand
Dehradun Call Girls 8854095900 Call Girl in Dehradun Uttrakhand
 
jabalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
jabalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetjabalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
jabalpur Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Independent Call Girls Hyderabad 💋 9352988975 💋 Genuine WhatsApp Number for R...
Independent Call Girls Hyderabad 💋 9352988975 💋 Genuine WhatsApp Number for R...Independent Call Girls Hyderabad 💋 9352988975 💋 Genuine WhatsApp Number for R...
Independent Call Girls Hyderabad 💋 9352988975 💋 Genuine WhatsApp Number for R...
 
Top 20 Famous Indian Female Pornstars Name List 2024
Top 20 Famous Indian Female Pornstars Name List 2024Top 20 Famous Indian Female Pornstars Name List 2024
Top 20 Famous Indian Female Pornstars Name List 2024
 
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in LahoreBest Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
Best Lahore Escorts 😮‍💨03250114445 || VIP escorts in Lahore
 
ooty Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
ooty Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetooty Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
ooty Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
dehradun Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
dehradun Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetdehradun Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
dehradun Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
Jaipur Call Girls 9257276172 Call Girl in Jaipur Rajasthan
Jaipur Call Girls 9257276172 Call Girl in Jaipur RajasthanJaipur Call Girls 9257276172 Call Girl in Jaipur Rajasthan
Jaipur Call Girls 9257276172 Call Girl in Jaipur Rajasthan
 
Jalna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Jalna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real MeetJalna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
Jalna Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 
❤️Call girls in Jalandhar ☎️9876848877☎️ Call Girl service in Jalandhar☎️ Jal...
❤️Call girls in Jalandhar ☎️9876848877☎️ Call Girl service in Jalandhar☎️ Jal...❤️Call girls in Jalandhar ☎️9876848877☎️ Call Girl service in Jalandhar☎️ Jal...
❤️Call girls in Jalandhar ☎️9876848877☎️ Call Girl service in Jalandhar☎️ Jal...
 
kochi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
kochi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meetkochi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
kochi Call Girls 👙 6297143586 👙 Genuine WhatsApp Number for Real Meet
 

Generating preference-based values for the EQ-5D-Y to support its use in HTA

  • 1. Koonal Shah, Office of Health Economics Oliver Rivero-Arias, National Perinatal Epidemiology Unit, Nuffield Department of Population Health, University of Oxford NICE Technical Forum  29 January 2019 Generating preference-based values for the EQ-5D-Y to support its use in HTA
  • 2. NICE Technical Forum, 29 January 2019 2 Acknowledgements • This presentation reports selected methods and findings from research supported by grants from the EuroQol Research Foundation and the Spanish Department of Health • The views expressed do not necessarily reflect the views of the funders
  • 3. NICE Technical Forum, 29 January 2019 3 Outline • Introduction to measuring and valuing child health • EQ-5D-Y • Brief primer on QALYs, measurement and valuation • Valuation challenges • Findings from recent EQ-5D-Y valuation research • Suggested points for discussion
  • 4. NICE Technical Forum, 29 January 2019 4 Measuring and valuing child health • Increasing research and HTA interest in measuring and valuing the health of children and adolescents • Measures available for measuring child health, e.g. PedQL, KIDSCREEN • These measures provide summary scores across dimensions, but are not preference-based • Not suitable for use in the estimation of QALYs • Generic preference-based measures developed specifically for use in younger populations are also now available – HUI2, CHU9D • EQ-5D-Y – ‘youth’ version of the EQ-5D
  • 5. NICE Technical Forum, 29 January 2019 5 EQ-5D-Y instrument Developed in 2010 for use in children and adolescents aged 8 to 15 years
  • 6. NICE Technical Forum, 29 January 2019 6 Brief primer on QALYs, description and valuation • Quality-adjusted life years: a measure of health captures both quality of life and length of life • Quality of life is used to ‘weight’ patients’ life years • Quality of life scale is anchored at 1 = full health, 0 = dead • 1 QALY = a year of perfect health Time (Years) Quality of life scale (0-1) 0 1 Health profile of a CF adolescent with current treatment Mild State Moderate State Severe State Transplant State 40
  • 7. NICE Technical Forum, 29 January 2019 7 Brief primer on QALYs, description and valuation • The ‘quality adjustment’ in QALYs requires two pieces of information: 1. A description of patients’ health (e.g. using self/proxy-reported EQ- 5D-Y health states)… 2. …and the valuation (on a scale anchored at 0 and 1) of those health states
  • 8. NICE Technical Forum, 29 January 2019 8 For every health state, there is a ‘value’ on a 0-1 anchored scale Obtaining ‘values’ for health states
  • 9. NICE Technical Forum, 29 January 2019 9 Example of an EQ-5D ‘value set’
  • 10. NICE Technical Forum, 29 January 2019 10 How do we get the values? • We typically ask members of the general public to complete stated preference ‘choice-based’ exercises • These involve considering a range of different health states, imagining what it would be like to experience them, and indicating how good or bad they are • For decision making, we need a set of ‘values’ that represents the overall view of the relevant population • Preference elicitation techniques: • Rating scale (RS) • Standard gamble (SG) • Time trade-off (TTO) • Discrete choice experiment (DCE)
  • 11. NICE Technical Forum, 29 January 2019 11 EQ-5D-Y: state of play • >40 language versions available • Use is modest but growing • Demand for use in HTA, but no value sets to support that • Recent research has indicated that regular EQ-5D-3L value sets cannot be used for children and adolescents
  • 12. NICE Technical Forum, 29 January 2019 12 Valuation challenges • Normative issues (whose preferences should we elicit?) • Perspective issues (whose health should we elicit the preferences for?) • Methods issues (how do we elicit the preferences, and on what basis do we make this choice?) • VAS values lower for EQ-5D-Y than for EQ-5D-3L (Kind et al., 2015) • TTO values higher for EQ-5D-Y (Kreimeier et al., 2015) – possibly due to reluctance to sacrifice life years for children
  • 13. NICE Technical Forum, 29 January 2019 13 Whose preferences? • Position adopted by decision makers in the UK, US, Netherlands (amongst others): relevant preferences are those of the general public • EuroQol protocol: EQ-5D value sets should be based on the preferences of the general public, not of the subgroup whose health is being evaluated • Reflects fact that HTA is intended to inform the broad allocation of resources across an entire population / health system • Public = taxpayers and potential users of health care • Societal perspective, insurance principle, adaptation arguments
  • 14. NICE Technical Forum, 29 January 2019 14 Who counts as the public? • The UK is not prescriptive about who constitutes a member of the public, but there seems to be an implicit consensus: • Those who bear the cost of providing health care • Those eligible to vote • These criteria exclude children and adolescents
  • 15. NICE Technical Forum, 29 January 2019 15 Alternative view • Preferences of children and adolescents are relevant because they are potential patients / users of the health care being evaluated • May be relevant to understand the preferences of children (as patients) – could be relevant in other, non-HTA uses of the instrument (Versteegh and Brouwer, 2016) • Alternatives to conventional techniques now available that may be suitable for eliciting the preferences of younger people
  • 16. NICE Technical Forum, 29 January 2019 16 15. To put the above principles into practice on matters that affect children and young people’s health and wellbeing, NICE has adopted the following overarching aim: • To involve children and young people, (and the organisations that represent their interests), on matters pertinent to NICE’s work and that affect children and young people’s health and wellbeing. 16. In pursuit of this aim, NICE is committed to: • ensuring that the perspectives of children and young people – including those who share the protected characteristics of the Equality Act 20102 or live in disadvantaged circumstances – are taken into account in relevant areas of NICE’s work • producing guidance and standards on topics covering children and young people’s health and wellbeing, which have been informed and influenced by their views and experiences Extract from NICE Patient and Public Involvement Policy (pp.6-7)
  • 17. NICE Technical Forum, 29 January 2019 17 Whose health? • If we are to use adult preferences to value child health instruments, whose health should they be valuing? • Their own health? • Their own health, imagining they are a child? • The health of their own child? • The health of an unidentified child? – How old should the child be, given the range of ages covered by different instruments?
  • 18. NICE Technical Forum, 29 January 2019 18 What approaches have been used to develop value sets of instruments for paediatric populations? Instrument Country Sample Perspective Elicitation method QWB USA Adults Self RS HUI Mark 2 Canada Adults Child perspective SG/RS HUI Mark 3 Canada Adults Self SG/RS 16D Finland Adolescents Self RS 17D Finland Adults Child perspective RS AQoL-6D Australia Adolescents Self TTO AHUM UK Adults Self TTO CHU-9D UK Adults Self SG CHU-9D Australia Adolescents Self DCE EQ-5D-Y USA Adults Child perspective DCE QWB: Quality of Well-Being Scale; HUI: Health Utility Index; 16D: sixteen- dimensional measure of health-related quality of life; 17D: seventeen- dimensional measure of health-related quality of life; AQoL-6D: Assessment of Quality of Life 6-Dimension; CHU-9D: Child Health Utility 9D; AHUM: Adolescent Health Utility Measure; RS: rating scale, SG: standard gamble, TTO: time trade- off; DCE: discrete choice experiment
  • 19. NICE Technical Forum, 29 January 2019 19 Recent EQ-5D-Y valuation research • Conduct a discrete choice experiment to obtain preferences for EQ-5D-Y health states using a sample of adults. Values obtained on a latent scale (not a QALY scale) Study 1: Latent scale DCE study – adult version Study 3: Anchoring study • In parallel, test a range of methods for anchoring latent scale values at 0 = dead to convert latent scale of DCE values into QALY scale • Not covered in this presentation Study 2: Latent scale DCE study – adolescent version • Replicate study 1 using a sample of adolescents
  • 20. NICE Technical Forum, 29 January 2019 20 Study 1: Latent Scale DCE Adults • Online discrete choice experiment (DCE) survey • Participants belonging to an online panel: quotas used for gender, age and social grade
  • 21. NICE Technical Forum, 29 January 2019 21 Study 1: Latent Scale DCE Adults • 1,000 adults (+18) completing the survey from the perspective of a “10-year old child” • We used a Blocked Bayesian efficient design to identify 150 pairs to present to participants • + fixed pair (one health state clearly dominant) • Survey instrument included: consent/screening, self-reported EQ-5D-Y, DCE exercise, debriefing, background questions • Data collection during February-March 2017
  • 22. NICE Technical Forum, 29 January 2019 22 Study 1: Latent Scale DCE Adults • Discrete choice modelling used to analysis DCE data • multinomial logit, scaled multinomial logit; mixed logit; generalised multinomial logit and latent class • Relative attribute importance of model parameters of EQ-5D-Y levels • Participant engagement with the elicitation task
  • 23. NICE Technical Forum, 29 January 2019 23 Study 2: Latent Scale DCE Adolescents • Same design of Study 1 • 1,005 adolescents (11-17 years old) completing the survey from their own perspective • Data collection during February-March 2018
  • 24. NICE Technical Forum, 29 January 2019 24 Selected background characteristics Adolescents (own health) (n=1,005) Adults (child perspective) (n=1,000) Family affluence scale (FAS) Low FAS score 29 (2.9%) - Medium FAS score 456 (45.4%) - High FAS score 519 (51.6%) - Missing values 1 (0.1%) Education Did not continue education - 230 (23.0%) Continued education (no degree) - 315 (31.5%) Continued education (degree) - 455 (45.5%) Experience of serious illness In self - 312 (31.2%) In friends or family - 629 (62.9%) In caring for others - 279 (27.9%) Self-reported health EQ-5D-Y health state 11111 587 (58.4%) 148 (14.8%) Other EQ-5D-Y health states 418 (41.6%) 852 (85.2%) Samples were representative of the UK general population in terms of age, gender, grade and nation
  • 25. NICE Technical Forum, 29 January 2019 25 Relative attribute importance model parameters of EQ-5D-Y levels Levels Adolescents (own health) Mean (95% CI) Adults (child perspective) Mean (95% CI) Statistically significant differences in preferences? MO2 Some problems 3.7 (2.8 to 4.7) 3.2 (2.3 to 4.1) MO3 Lot of problems 12.9 (11.9 to 13.9) 9.4 (8.3 to 10.5) * SC2 Some problems 3 (2.2 to 3.8) 2.9 (2.1 to 3.6) SC3 Lot of problems 10.2 (9.2 to 11.2) 7.7 (6.7 to 8.6) UA2 Some problems 4.5 (3.8 to 5.3) 4.8 (4 to 5.5) UA3 Lot of problems 12.1 (11.2 to 13.1) 11.6 (10.7 to 12.5) PD2 Some pain 7.5 (6.5 to 8.4) 8.8 (7.9 to 9.7) PD3 Lot of pain 21.1 (19.6 to 22.7) 24 (22.2 to 25.7) * AD2 Bit worried 5.2 (4.3 to 6) 7.4 (6.5 to 8.4) * AD3 Very worried 19.7 (18.1 to 21.3) 20.3 (18.7 to 21.9) * MO: Mobility; SC: Self-care; UA: Usual activities; PD: Pain/Discomfort; AD: Worried, sad or unhappy Red figures indicate three parameters with largest contributions
  • 26. NICE Technical Forum, 29 January 2019 26 Participant engagement with DCE State 11122 vs 22233 Adolescents Adults Proportion selecting state 11122 88.46% 89.5% Adults (child perspective)Adolescents
  • 27. NICE Technical Forum, 29 January 2019 27 Debriefing questions (freq.,%) Adolescents Adults Found the tasks difficult: Strongly disagree 208 (20.70%) 217 (21.70%) Disagree 307 (30.55%) 290 (29.00%) Neither agree nor disagree 224 (22.29%) 226 (22.60%) Agree 226 (22.49%) 224 (22.40%) Strongly agree 40 (3.98%) 43 (4.30%) Found difficult to imagine the health problems described Strongly disagree 105 (10.45%) 185 (18.50%) Disagree 248 (24.68%) 329 (32.90%) Neither agree nor disagree 213 (21.19%) 209 (20.90%) Agree 369 (36.72%) 206 (20.60%) Strongly agree 70 (6.97%) 71 (7.10%)
  • 28. NICE Technical Forum, 29 January 2019 28 • DCE did not include dead or a duration attribute, so values are on a ‘latent’ (or undefined) scale • Further info needed to rescale latent scale values so that they are anchored at 0 and 1, as required for QALY calculations • Which anchoring method should be used? Possible criteria: • Feasibility • Acceptability to decision makers • Potential for administration online • Theoretical and empirical coherence with the preference data to be anchored • Theoretical and empirical consistency with adult valuations in use in HTA Need for anchoring
  • 29. NICE Technical Forum, 29 January 2019 29 Some discussion points • Which perspective should be employed? • Is the relevant and realistic to use adolescent preferences? • How important is it that the methods used for child health health valuation are commensurate with those used for adult health valuation? • Which stakeholders should feed into these decisions?
  • 30. NICE Technical Forum, 29 January 2019 30 To enquire about additional information and analyses, please contact Koonal Shah at kshah@ohe.org To keep up with the latest news and research, subscribe to our blog, OHE News Follow us on Twitter @OHENews, LinkedIn and SlideShare Office of Health Economics (OHE) Southside, 7th Floor 105 Victoria Street London SW1E 6QT United Kingdom +44 20 7747 8850 www.ohe.org OHE’s publications may be downloaded free of charge from our website. Thank you for listening